Diligence memo · auto-generated · as of July 2, 2026
Endochoice, Inc.
Endochoice, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Endochoice, Inc. operates in Other Health Care, based in ALPHARETTA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Endochoice, Inc. has raised $15M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $7.6M on 2010-06-15.
Most recent recorded round closed around 2010-12-30.
Valuation (modeled)modeled
Provath models Endochoice, Inc. at approximately $91M (range $5.8M–$492M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.78× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era. Within the normal band (78% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 15.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 81% of Other Health Care peers (5377 compared).
Modeled value ranks above 77% of those peers.
Closest niche peers: Barrx Medical Inc, Icad Inc, Cas Medical Systems Inc, Cardiosolutions Inc, Ophthonix Inc.
Peoplefiled
22 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.